Annovis Bio Inc (ANVS)

$ANVS im Here 4 the Maria Special

$ANVS They all want to see our circus!

$ANVS 10,000

$ANVS Who is the 10k watcher?

$ANVS Just realised that we are one person shy of 10k watchers- current or potential investors.

$ANVS Every OTC/pump board needs its enforcers to try and keep the board clean. Thanks Phil, for making my point.

$ANVS I am holding my shares and adding shares for unblinding.

$ANVS I guess that majority of investors are holding for unblinding.

$ANVS No volume.

$ANVS is there nothing that makes this stock go up? Q1 2027 better be damned good results.

$ANVS August 14th is the next update on institutions buy ins- we will see if they are still buying

$ANVS BiiB just displayed phase 2 Alzheimers data is worth 2 Billion in market cap Whats Phase 3 Alzheimers worth???

$ANVS That price target

$ANVS Following the institutions here. The trend is your friend

$ANVS Watching Maria's Stocktwits interview, she presented as quite inspired about future trials for Parkinson’s. While I wish she qualified her desire for another Phase 3 with “if we have the money to do so,“ her enthusiasm made me curious. In mid-March, the Parkinson's open-label extension announced they had enrolled approximately 100 patients. It has now been over three months since that update. This means they officially have movement data from the Apple Watches and readings on alpha-synuclein for roughly a three-month period. Because it is an open-label study, management has a direct window into these incoming data streams. Could her enthusiasm be precipitated by this exact dataset? It would be compelling if they demonstrate a statistically significant drop in both tremors and alpha-synuclein. This would potentially be risk the asset significantly. $GANX $AVXL Phase 3 enrolment complete. Nearest shot to new drug application. They also have 6 month data for some in OLE.

$ANVS that crazy spike... 👀

An $ANVS truth @ReturnOfEsquire that's a 100% accurate. Maybe "900%" accurate 😂 if I were to quote Dr. Maccecchini. All the former CFOs wish for is to forget they were ever associated with Dr. Maccecchini and her sham of a company, Annovis Bio. I have no idea how or with what she will be using to lured fresh CFO replacement meat into her lair. Perhaps it was a typo ... or, perhaps a subconscious slip, but even former CFO #MarkGuerin of Annovis Bio has incorrectly associated himself with $AVXL (a company that he has never been a CFO at). See Image 1. That's from, "The Road Ahead: Perspectives from CFGI Philadelphia": https://www.cfgi.com/2026/05/26/the-road-ahead-perspectives-from-cfgi-philadelphia/ See Image 2. Image 3 speaks for itself, but as you've so accurately described, Jim, most members of this OTC-esque Stocktwits channel will explain this image with excuses such as all the five (5) former CFOs were not worth their salt, letting Dr. Maccecchini down, being failures, and/or the many negative things she no doubt spews to shareholders in private communications despite her legal counsel warning her and telling her to "Shut up". Yes, that's a quote from Dr. Maccecchini herself about what her legal counsel told her. But, alas this type of behavior is apparently something that Dr. Maccecchini is likely proud since she shares this so unabashedly. I'd let this go if it wasn't for the fact that Dr. Maccecchini is poaching families and patients to buy her stock. I wish she would stop, but I know she won't : ( See Image 4 ... which is abhorrent. P.S. You are correct that if Annovis Bio's molecule fails, it has nothing to do with big pharma. It also won't have anything to do with biomarkers, patients, and/or Clinical Research Organizations (CMO) that Dr. Maccecchini has publicly blames. She on the record for public stating that grandmothers faked Alzheimer's and I know she's screamed at representatives for what in my opinion are the failings of her own mismanagement and poorly designed drug trials and their protocols. Ugg. I'm going to try to let this go ... Tagging the following CNS companies as a warning to those shareholders in the same space to keep away from Annovis Bio: $SLS $CGTX $LLY

$ANVS This board has devolved into an OTC-esque, platitude-laden pump fest. I hope this molecule works, but I'm fairly convinced it doesn't. I hope I'm wrong. But if it fails, it has nothing to do with big pharma.

$ANVS go find a cheaper Alzheimers phase 3 data play.... Choices are LLY- trades at $1,152 a share aprx, or BiiB - trades at $192 a share aprx

$ANVS Never seen such an opportunity where retail has advantage over institutions. Some institutions cant buy shares below particular price ranges. Retail has no rules on what price they can buy. Anvs shares were more expensive in Phase 1, more expensive in Phase 2, and here we are in Phase 3 trading near All time lows What a blessing

$ANVS another item to consider...many times, especially so with biotech, price action becomes bizzare and makes absolutely no sense, just like now. Its at these times, occasionally, that's when the buyout comes. I'm not saying that Maria is ready to do this now. But I've seen weird price action precede buyout offers. Not that someone would ever manipulate stock price...Lol!

$ANVS Sorry for the price action. The market cap is so low computer programs buying and selling a tiny amount of stock at a time change the price. Shorts always do it. Other traders also do this as hedge funds add positions. At some point in the near future they will allow the price to climb. It is always like this with good news and small pharma. The sad story is retail traders sell their shares. Understand the science and keep your shares. Or better yet buy some. I think this a once in a lifetime opportunity. Price will be the same regardless in 6 months. On my ledger, you are helping me because of cheap shares to buy. However, that is not the point. Help yourself.